Evaluation of the customer issue included a complaint text review, a search for similar complaints, device history review, and labeling review.The product was not returned.No adverse trend was identified for the customer issue.Device history review did not identify any issues that may have caused the customer issue.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics evaluation, no systemic issue was identified and no product deficiency was found.
|
The customer observed falsely depressed results while using clinical chemistry total bilirubin reagents.The following data was provided for the same newborn patient.The customer uses normal range 0.3 to 1.5 mg/dl and critical value greater than 14.9 mg/dl.Sid: (b)(6).Specimen drawn on (b)(6) 2018 at 30 hours of life was lower, 0.4 mg/dl.Previous and subsequent specimen results for the same patient were higher.Specimen drawn on (b)(6) 2018, at 3 hours of life, 3.5 mg/dl.Specimen drawn on (b)(6) 2018 at 29 hours of life) initial 29.0 mg/dl.Specimens drawn on (b)(6) 2018 12.0, 13.0 mg/dl.Specimen drawn on (b)(6) 2018 10.7 mg/dl.Advance br2 method was higher for the specimen drawn on (b)(6) 2018 at 30 hours (8.6 mg/dl).No adverse impact to patient management was reported.
|